SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-006110
Filing Date
2024-04-29
Accepted
2024-04-29 16:10:17
Documents
8
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240612xdef14a.htm DEF 14A 1250407
2 GRAPHIC tmb-20240612xdef14a_a003.jpg GRAPHIC 6350
3 GRAPHIC tmb-20240612xdef14a_a004.jpg GRAPHIC 3009
4 GRAPHIC tmb-20240612xdef14a_a005.jpg GRAPHIC 3060
5 GRAPHIC tmb-20240612xdef14a_a010.jpg GRAPHIC 46589
6 GRAPHIC tmb-20240612xdef14a_a011.jpg GRAPHIC 46737
7 GRAPHIC tmb-20240612xdef14a_bg001.jpg GRAPHIC 132675
8 GRAPHIC tmb-20240612xdef14a_bg002.jpg GRAPHIC 107394
  Complete submission text file 0001558370-24-006110.txt   1728752
Mailing Address 15 CROSBY DRIVE BEDFORD MA 01730
Business Address 15 CROSBY DRIVE BEDFORD MA 01730 781-357-4000
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36554 | Film No.: 24890797
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)